Medivation and Pfizer announce results from Phase 3 Concert trial of dimebon in Alzheimer’s disease
17 January 2012 | By Pfizer
Dimebon did not meet primary efficacy endpoints...
List view / Grid view
News
Pan-European stroke prevention in atrial fibrillation registry – PREFER in AF – enrols first patient
16 January 2012 | By Weber Shandwick
Enrolment of the first patient into the PREvention oF thromboembolic events...
Lundbeck awarded prize for world-class production
16 January 2012 | By H. Lundbeck A/S
H. Lundbeck A/S has crowned six years of focused efforts on productivity improvements with a silver medallion...
Novartis to restructure US business to strengthen competitive position in light of loss of Diovan® patent
13 January 2012 | By Novartis
US General Medicines restructuring results in reduction of 1,960 positions...
Bristol-Myers Squibb begins tender offer to acquire Inhibitex, Inc.
13 January 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company is commencing a cash tender offer to purchase all outstanding shares of common stock of Inhibitex...
Gilead Sciences completes tender offer for all outstanding shares of Pharmasset, Inc.
12 January 2012 | By Gilead Sciences
Following the merger, Pharmasset will become a wholly-owned subsidiary of Gilead...
B&W Tek to introduce micro lensed fiber-optic Raman probe at SPIE’s BiOS & Photonics West exhibits
12 January 2012 | By B&W Tek Inc
B&W Tek, Inc., is proud to introduce the BAC200...
B&W Tek celebrates 15 years of innovative solutions for photonics
12 January 2012 | By B&W Tek, Inc
In the last 15 years B&W Tek has experienced substantial growth in size, value, skills and core competencies...
Flavor and fragrance production with the Syrris Atlas Calorimeter
IFF, a leading global creator of flavors and fragrances, uses the Syrris Atlas Calorimeter for flavor and fragrance development at its production plant in Benicarlo, Spain.
Tecan’s Infinite® M1000 and a plate of live fish!
11 January 2012 | By kdm communications limited
Tecan’s Infinite® M1000 multimode microplate reader has enabled scientists to develop a high throughput system...
GSK responds to the recent court ruling on the COMPAS study in Mendoza, Argentina
11 January 2012 | By GlaxoSmithKline
GlaxoSmithKline respectfully disagrees with the recent court ruling in favour of ANMAT...
AstraZeneca and IMS Health announce real-world evidence collaboration in Europe
11 January 2012 | By AstraZeneca
AstraZeneca has entered into a three-year collaboration agreement with IMS Health...
Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, jointly launch Warp Drive Bio
10 January 2012 | By Sanofi
Sanofi is co-investing in Warp Drive Bio, an innovative start-up biotechnology company...
SFJ Pharma Ltd. II announces agreement with Pfizer to develop Axitinib
9 January 2012 | By Citigate Dewe Rogerson
SFJ announced that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial...
AstraZeneca reaffirms December 2011 financial guidance for 2011 and mid-term planning assumptions for the 2010 to 2014 period
9 January 2012 | By AstraZeneca
The info was out of date planning information...
